CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats

Open Access

Peer-reviewed

Research Article

Shan Lang,

Affiliation Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
⨯
Libing Li,

Affiliation Department of Cardiovascular Surgery, Chinese PLA General Hospital, Beijing, China
⨯
Xuning Wang,

Affiliation Department of Surgical Oncology, Chinese PLA General Hospital, Beijing, China
⨯
Junping Sun,

Affiliation Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
⨯
Xinying Xue,

Affiliation Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
⨯
Yongjiu Xiao,

Affiliation Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
⨯
Mingyue Zhang,

Affiliation Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
⨯
Ting Ao,

Affiliation Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
⨯
Jianxin Wang

* E-mail: wangjianxin301@yeah.net

Affiliation Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China
⨯

Reader Comments (0)

Neutrophils
Is the Subject Area "Neutrophils" applicable to this article?

Thanks for your feedback.
Acute respiratory distress syndrome
Is the Subject Area "Acute respiratory distress syndrome" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Chemokines
Is the Subject Area "Chemokines" applicable to this article?

Thanks for your feedback.
Edema
Is the Subject Area "Edema" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.